Cognitive behavioral therapy (CBT) in the smartphone age
This whitepaper closely examines digital treatments — with a particular focus on solutions rooted in cognitive behavioral therapy (CBT). By weighing the pros and cons of each category, you can determine which digital treatment options best suit your organization’s unique needs.
![](https://cdn.prod.website-files.com/65d5520ef65eaba833ec52bb/65d5520ef65eaba833ec558e_0623_BHJuneWhitepaper_thumbnail-01-912x512%20(1).png)
In the era of iPhones, digital solutions are available to address almost every concern imaginable, such as insomnia and anxiety. A search for insomnia-related tools in the Apple app store yields dozens of results, offering everything from sleep-inducing sounds to hypnosis to breathing exercises. Not all apps, however, are created equal.
How can you identify truly effective solutions, particularly when selecting apps to address the mental health of your organization? This whitepaper closely examines digital treatments — with a particular focus on solutions rooted in cognitive behavioral therapy (CBT). By weighing the pros and cons of each category, you can determine which digital treatment options best suit your organization’s unique needs.
Key insights
- Learn about the different types of digital solutions on the market
- Recognize the value of CBT-based treatments and what sets them apart
- Understand how CBT-based treatments fit into your existing benefits package
- Assess solutions to help restore the mental health of your employees
Get a peek inside
![](https://cdn.prod.website-files.com/65d5520ef65eaba833ec52bb/65d5520ef65eaba833ec555f_0323_MillimanLandingPageImage-1-1024x518.png)
Download the report
During the COVID-19 public health emergency, Sleepio and Daylight are being made available as treatments for insomnia disorder and generalized anxiety disorder (GAD), respectively, without a prescription. Sleepio and Daylight have not been cleared by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia disorder and GAD, respectively.
1. Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.2. Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … & Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700.3. Wilson, S., Anderson, K., Baldwin, D., Dijk, D. J., Espie, A., Espie, C., … & Sharpley, A. (2019). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. Journal of Psychopharmacology, 33(8), 923-947.4. King’s Technology Evaluation Centre. (2017, November 9). Overview: Health app: SLEEPIO for adults with poor Sleep: Advice. NICE. https://www.nice.org.uk/advice/mib129.5. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769-781.6. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A., … & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and Anxiety, 37(12), 1168-1178.
DOC-3046 Effective 11/2023